S&P 500   3,841.94
DOW   31,496.30
QQQ   308.68
S&P 500   3,841.94
DOW   31,496.30
QQQ   308.68
S&P 500   3,841.94
DOW   31,496.30
QQQ   308.68
S&P 500   3,841.94
DOW   31,496.30
QQQ   308.68
Log in

Viemed Healthcare Stock Forecast, Price & News

-0.11 (-1.13 %)
(As of 03/5/2021 12:00 AM ET)
Today's Range
Now: $9.59
50-Day Range
MA: $9.51
52-Week Range
Now: $9.59
Volume491,395 shs
Average Volume217,437 shs
Market Capitalization$375.78 million
P/E Ratio13.32
Dividend YieldN/A
Viemed Healthcare, Inc., through its subsidiaries, provides in-home durable medical equipment and health care solutions to patients in the United States. The company offers respiratory services and related equipment, including non-invasive ventilators; bi-level, continuous, and automatic continuous positive airway pressure (PAP) machines; and oxygen units, as well as services of respiratory therapists; and respiratory disease management, neuromuscular care, and oxygen therapy services. It also provides in-home sleep apnea testing services to determine the existence of sleep apnea at home. In addition, the company leases non-invasive and invasive ventilators, PAP machines, percussion vests, oxygen concentrator units, and respiratory equipment, as well as sells medical equipment and/or patient medical services. Further, it provides therapy and counseling to patients in their homes using its technology. The company was founded in 2006 and is headquartered in Lafayette, Louisiana.

Industry, Sector and Symbol

Industry Miscellaneous health & allied services, not elsewhere classified
Current SymbolNASDAQ:VMD
Phone337 504 3802
Year FoundedN/A



Sales & Book Value

Annual Sales$80.26 million
Cash Flow$0.44 per share
Book Value$1.15 per share


Net Income$8.52 million


Market Cap$375.78 million
Next Earnings Date5/3/2021 (Estimated)
OptionableNot Optionable


Overall MarketRank

1.48 out of 5 stars

Medical Sector

513th out of 1,969 stocks

Miscellaneous Health & Allied Services, Not Elsewhere Classified Industry

7th out of 25 stocks

Analyst Opinion: 3.3Community Rank: 2.0Dividend Strength: 0.0Insider Behavior: 0.8Valuation: 1.3 5 -4 -3 -2 -1 -
-0.11 (-1.13 %)
(As of 03/5/2021 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive VMD News and Ratings via Email

Sign-up to receive the latest news and ratings for VMD and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles

Viemed Healthcare (NASDAQ:VMD) Frequently Asked Questions

Is Viemed Healthcare a buy right now?

3 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Viemed Healthcare in the last twelve months. There are currently 1 hold rating and 2 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" Viemed Healthcare stock.
View analyst ratings for Viemed Healthcare
or view top-rated stocks.

What stocks does MarketBeat like better than Viemed Healthcare?

Wall Street analysts have given Viemed Healthcare a "Buy" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Viemed Healthcare wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

When is Viemed Healthcare's next earnings date?

Viemed Healthcare is scheduled to release its next quarterly earnings announcement on Monday, May 3rd 2021.
View our earnings forecast for Viemed Healthcare

What price target have analysts set for VMD?

3 equities research analysts have issued 1 year price targets for Viemed Healthcare's stock. Their forecasts range from $12.00 to $13.00. On average, they anticipate Viemed Healthcare's share price to reach $12.50 in the next twelve months. This suggests a possible upside of 30.3% from the stock's current price.
View analysts' price targets for Viemed Healthcare
or view top-rated stocks among Wall Street analysts.

Who are Viemed Healthcare's key executives?

Viemed Healthcare's management team includes the following people:
  • Mr. Casey Hoyt, CEO & Director (Age 44, Pay $1.13M)
  • Mr. Michael B. Moore, Pres (Age 43, Pay $1.03M)
  • Mr. Trae Paul Fitzgerald, Chief Financial Officer (Age 32, Pay $433k)
  • Mr. William Todd Zehnder, COO & Director (Age 46, Pay $1M)
  • Mr. Jerome Richard Cambre II, VP of Sales (Age 50, Pay $462.47k)
  • Dr. William Dana Frazier, Chief Medical Officer & Director (Age 63)
  • John Collier, Chief Technology Officer
  • Claudio Munoz, Chief Information Officer
  • Mr. Brett Stoute, Chief Compliance Officer
  • Rob Birkhead, Chief Marketing Officer

Who are some of Viemed Healthcare's key competitors?

What is Viemed Healthcare's stock symbol?

Viemed Healthcare trades on the NASDAQ under the ticker symbol "VMD."

How do I buy shares of Viemed Healthcare?

Shares of VMD can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Viemed Healthcare's stock price today?

One share of VMD stock can currently be purchased for approximately $9.59.

How much money does Viemed Healthcare make?

Viemed Healthcare has a market capitalization of $375.78 million and generates $80.26 million in revenue each year. The company earns $8.52 million in net income (profit) each year or $0.21 on an earnings per share basis.

How many employees does Viemed Healthcare have?

Viemed Healthcare employs 499 workers across the globe.

What is Viemed Healthcare's official website?

The official website for Viemed Healthcare is www.viemed.com.

Where are Viemed Healthcare's headquarters?

Viemed Healthcare is headquartered at 625 East Kaliste Saloom Road, Lafayette LA, 70508.

How can I contact Viemed Healthcare?

Viemed Healthcare's mailing address is 625 East Kaliste Saloom Road, Lafayette LA, 70508. The company can be reached via phone at 337 504 3802 or via email at [email protected]

This page was last updated on 3/7/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.